Caseware UK (AP4) 2023.0.135 2023.0.135 2024-06-302024-06-302023-07-01falseNo description of principal activity55truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 13126170 2023-07-01 2024-06-30 13126170 2022-07-01 2023-06-30 13126170 2024-06-30 13126170 2023-06-30 13126170 c:Director3 2023-07-01 2024-06-30 13126170 d:ComputerEquipment 2023-07-01 2024-06-30 13126170 d:ComputerEquipment 2024-06-30 13126170 d:ComputerEquipment 2023-06-30 13126170 d:ComputerEquipment d:OwnedOrFreeholdAssets 2023-07-01 2024-06-30 13126170 d:DevelopmentCostsCapitalisedDevelopmentExpenditure 2023-07-01 2024-06-30 13126170 d:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-06-30 13126170 d:DevelopmentCostsCapitalisedDevelopmentExpenditure 2023-06-30 13126170 d:CurrentFinancialInstruments 2024-06-30 13126170 d:CurrentFinancialInstruments 2023-06-30 13126170 d:CurrentFinancialInstruments d:WithinOneYear 2024-06-30 13126170 d:CurrentFinancialInstruments d:WithinOneYear 2023-06-30 13126170 d:ShareCapital 2024-06-30 13126170 d:ShareCapital 2023-06-30 13126170 d:SharePremium 2024-06-30 13126170 d:SharePremium 2023-06-30 13126170 d:RetainedEarningsAccumulatedLosses 2024-06-30 13126170 d:RetainedEarningsAccumulatedLosses 2023-06-30 13126170 c:OrdinaryShareClass1 2023-07-01 2024-06-30 13126170 c:OrdinaryShareClass1 2024-06-30 13126170 c:OrdinaryShareClass1 2023-06-30 13126170 c:OrdinaryShareClass2 2023-07-01 2024-06-30 13126170 c:OrdinaryShareClass2 2024-06-30 13126170 c:OrdinaryShareClass2 2023-06-30 13126170 c:FRS102 2023-07-01 2024-06-30 13126170 c:AuditExempt-NoAccountantsReport 2023-07-01 2024-06-30 13126170 c:FullAccounts 2023-07-01 2024-06-30 13126170 c:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 13126170 d:DevelopmentCostsCapitalisedDevelopmentExpenditure d:ExternallyAcquiredIntangibleAssets 2023-07-01 2024-06-30 13126170 e:PoundSterling 2023-07-01 2024-06-30 iso4217:GBP xbrli:shares xbrli:pure

Registered number: 13126170









AIDE HEALTH LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 30 JUNE 2024

 
AIDE HEALTH LIMITED
REGISTERED NUMBER: 13126170

STATEMENT OF FINANCIAL POSITION
AS AT 30 JUNE 2024

2024
2023
Note
£
£

Fixed assets
  

Intangible assets
 5 
393,100
271,720

Tangible assets
 6 
10,545
13,377

Current assets
  

Debtors: amounts falling due within one year
 7 
31,833
70,484

Cash at bank and in hand
 8 
45,767
453,895

  
77,600
524,379

Creditors: amounts falling due within one year
 9 
(41,481)
(23,243)

Net current assets
  
 
 
36,119
 
 
501,136

Total assets less current liabilities
  
439,764
786,233

Net assets
  
439,764
786,233


Capital and reserves
  

Called up share capital 
 10 
14
14

Share premium account
  
1,215,214
1,115,214

Profit and loss account
  
(775,464)
(328,995)

  
439,764
786,233


Page 1

 
AIDE HEALTH LIMITED
REGISTERED NUMBER: 13126170
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 30 JUNE 2024

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 20 March 2025.




B Snyder
Director

Page 2

 
AIDE HEALTH LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

1.


General information

Aide Health Limited is a private company limited by shares and registered in England and Wales. The address of its registered office is 124 Finchley Road, London, NW3 5JS.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Functional and presentation currency

The Company's functional and presentational currency is GBP.

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.
The company generates revenue through the provision of licenses to healthcare organisations which are invoiced at the start of the licence period. The income is recognised over the licence period as stipulated in the contract with the health care organisation. Income is deferred where the licence period spans the reporting date. 

 
2.4

Research and development

In the research phase of an internal project it is not possible to demonstrate that the project will generate future economic benefits and hence, all expenditure on research shall be recognised as an expense when it is incurred. Intangible assets are recognised from the development phase of a project if and only if certain specific criteria are met in order to demonstrate the asset will generate probable future economic benefits and that its cost can be reliably measured. The capitalised development costs are subsequently amortised on a straight line basis over their useful economic lives. The asset is still in the development phase and therefore has not been amortised at the reporting date. 
If it is not possible to distinguish between the research phase and the development phase of an internal project, the expenditure is treated as if it were all incurred in the research phase only.

 
2.5

Government grants

Grants are accounted for under the accruals model as permitted by FRS 102. Grants of a revenue nature are recognised in the Statement of Income and Retained Earnings in the same period as the related expenditure.

Page 3

 
AIDE HEALTH LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

2.Accounting policies (continued)

 
2.6

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 
2.7

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of Financial Position. The assets of the plan are held separately from the Company in independently administered funds.

 
2.8

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

 
2.9

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives.

Depreciation is provided on the following basis:

Computer equipment
-
20%
straight line

Page 4

 
AIDE HEALTH LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

3.


Judgments in applying accounting policies and key sources of estimation uncertainty

The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported for assets and liabilities as at the reporting date and the amounts reported for revenues and expenses during the period. However, the nature of estimation means that actual outcomes could differ from those estimates.
Accruals
The company makes an estimate of accruals at the reporting date based on invoices received after the reporting date and work undertaken which has not been invoiced based on quotations or estimates of amounts that may be due for payment.
Development costs
These costs are held as an intangible asset on the Statement of Financial Position and amortised over the estimated useful economic life on an expected revenue basis.


4.


Employees

The average monthly number of employees, including directors, during the year was 5 (2023 - 5).


5.


Intangible assets




Development expenditure

£



Cost


At 1 July 2023
271,720


Additions
146,360


Disposals
(24,980)



At 30 June 2024

393,100






Net book value



At 30 June 2024
393,100



At 30 June 2023
271,720



Page 5

 
AIDE HEALTH LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

6.


Tangible fixed assets





Computer equipment

£



Cost or valuation


At 1 July 2023
14,161



At 30 June 2024

14,161



Depreciation


At 1 July 2023
784


Charge for the year on owned assets
2,832



At 30 June 2024

3,616



Net book value



At 30 June 2024
10,545



At 30 June 2023
13,377


7.


Debtors

2024
2023
£
£


Trade debtors
-
53,832

Other debtors
27,771
16,652

Prepayments and accrued income
4,062
-

31,833
70,484



8.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
45,767
453,895


Page 6

 
AIDE HEALTH LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

9.


Creditors: Amounts falling due within one year

2024
2023
£
£

Trade creditors
9,227
2,301

Other taxation and social security
21,772
-

Other creditors
5,274
5,561

Accruals and deferred income
5,208
15,381

41,481
23,243



10.


Share capital

2024
2023
£
£
Allotted, called up and fully paid



105,270 (2023 - 105,270) Ordinary shares of £0.0001 each
11
11
29,394 (2023 -29,394) Seed Preferred shares of £0.0001 each
3
3

14

14

Several employees have an option to purchase up to 11,950 Ordinary shares at a value of £9.10 per share.



11.


Pension commitments

The Company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the Company in an independently administered fund. The pension cost charge represents contributions payable by the Company to the fund and amounted to £9,729 (2023: £5,226). At the reporting date, amounts totalling £1,677 (2023: £1,995) were payable to the fund.


12.


Related party transactions

At the reporting date, the company owed the directors, amounts totalling £3,566  (2023: £3,566) which is included in other creditors. The amount is not subject to interest and is repayable on demand.
The company has not entered into any other transactions during the year with related parties that are material and that have not been concluded under normal market conditions.

 
Page 7